跳至主要内容
临床试验/NCT05487196
NCT05487196已完成2 期

Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia: A Randomized Controlled Quadruple Blinded Non-Inferiority Trial (CLASSIER Trial)

Grace Lim, MD, MS1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2022年9月28日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
88
试验地点
1
主要终点
Pain Burden, AUC (30 Minutes)

研究概览

简要总结

The purpose of this randomized controlled trial is to compare the effectiveness of epidural clonidine, dexmedetomidine, or fentanyl adjuncts for labor analgesia.

详细描述

Adjuncts for epidural labor analgesia have remained unchanged for decades, whereas changes in patient population and the opioid epidemic have created an increased demand for non-opioid alternative adjuncts to limit peripartum opioid exposure. This study aims to identify effective alternative and non-opioid adjunctive agents for epidural labor analgesia.

The opioid crisis in the United States has translated to an increasing number of pregnant women requiring care for labor and delivery. These trends have resulted in new questions about alternative epidural analgesia adjuncts besides lipophilic opioids (e.g., fentanyl and sufentanil) because: 1) many people with opioid or substance use disorder desire to avoid opioids in all formulations and routes of administration; and 2) epidural fentanyl or sufentanil administration for labor can potentially interfere with the accuracy of urine drug screening in the postpartum period, which has implications for postpartum social services considerations.

Some existing literature suggests that dexmedetomidine and clonidine are viable adjuncts to local anesthetics that offer a faster onset and a better quality of analgesia for patients requiring labor analgesia. However, the relative effectiveness of these adjunctive agents for labor analgesia have not been compared head-to-head. Better data on how these adjuncts compare with each other for labor analgesia efficacy, can result in more informed clinical care strategies.

This trial was initially initiated as a superiority design. After further scientific input, it was decided that a non-inferiority design would be more informative for the clinical question at hand. The hypothesis is that clonidine (Group C) and dexmedetomidine (Group D) are non-inferior to fentanyl (Group F) (usual care) as adjuncts for epidural labor analgesia. The null hypothesis is that clonidine and dexmedetomidine are inferior to fentanyl as adjuncts for epidural labor analgesia. Clinical Protocol specific methodology did not change throughout the trial and the full trial protocol document can be found in the relevant section below. An updated statistical analysis plan includes updated sample size calculations and has been reported to account for the noninferiority analysis plan. No data was analyzed prior to the completion of all data collection procedures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women greater than 18 years of age
  • American Society of Anesthesiologists (ASA) Physical Status 2 or 3
  • Term pregnancy (greater than 37 gestational weeks)
  • Planning epidural labor analgesia
  • Singleton pregnancy
  • Vertex presentation
  • Planned vaginal delivery

排除标准

  • Pre-eclampsia with or without severe features
  • New initiation of antihypertensive agent within 24 hours prior to enrollment
  • Uncontrolled systemic comorbidities [i.e., diabetes, hepatic, renal or cardiac]
  • Known or suspected fetal abnormalities
  • Allergy to study agents
  • Contra-indication to neuraxial anesthesia
  • Inability to communicate or participate in study procedures

研究组 & 干预措施

Clonidine

Experimental

Bolus dose at epidural initiation, through the epidural catheter:

10 ml Ropivacaine 0.1 % combined with a single dose of Clonidine 60 mcg

干预措施: Clonidine (Drug)

Clonidine

Experimental

Bolus dose at epidural initiation, through the epidural catheter:

10 ml Ropivacaine 0.1 % combined with a single dose of Clonidine 60 mcg

干预措施: Ropivacaine (Drug)

Dexmedetomidine

Experimental

Bolus dose at epidural initiation, through the epidural catheter:

10 ml Ropivacaine 0.1 % combined with a single dose of Dexmedetomidine 30 mcg

干预措施: Dexmedetomidine (Drug)

Dexmedetomidine

Experimental

Bolus dose at epidural initiation, through the epidural catheter:

10 ml Ropivacaine 0.1 % combined with a single dose of Dexmedetomidine 30 mcg

干预措施: Ropivacaine (Drug)

Ropivacaine + Fentanyl

Active Comparator

Bolus dose at epidural initiation, through the epidural catheter:

10 ml Ropivacaine 0.1 % combined with a single dose of Fentanyl 100mcg

干预措施: Fentanyl (Drug)

Ropivacaine + Fentanyl

Active Comparator

Bolus dose at epidural initiation, through the epidural catheter:

10 ml Ropivacaine 0.1 % combined with a single dose of Fentanyl 100mcg

干预措施: Ropivacaine (Drug)

结局指标

主要结局

Pain Burden, AUC (30 Minutes)

时间窗: First 30 minutes of analgesia

Pain score AREA UNDER THE CURVE (AUC), which is a calculated area under curve using the trapezoidal rule, where pain scores measured from 0 (no pain) to 10 (worst imaginable pain) are on the y axis, and time is on the x axis (pain scores were measured at 5 minutes, 10 minutes,15 minutes, 30 minutes after epidural initiation for the primary outcome assessment). The scale for AUC is not 0-10 but rather is completely dependent upon the area generated under the curve created by pain scores for the first 30 minutes of epidural analgesia (primary outcome time frame): in this case, the scale is 0-250 pain units\*minute, given maximum pain score possibility of 10 and time period of 30 minutes. The units of AUC are the units of Y axis times units of X axis, in this case, pain score units \* minutes. Pain AUC was compared between Fentanyl, Clonidine and Dexmedetomidine groups.

次要结局

  • Patient Treatment Satisfaction(Immediately after delivery)
  • Newborn Apgar Score(1 minute after delivery)
  • Pain Burden, AUC (120 Minutes)(First 120 minutes of analgesia)
  • Pain Scores(Immediately after delivery)
  • Cesarean Delivery(At the time of delivery)
  • Hypotension(Between 0-120 min after study drug administration)
  • Nausea(0-120 min after study drug administration)
  • Vomiting(0-120 min after study drug administration)
  • Shivering(0-120 min after study drug administration)
  • Pruritus(0-120 min after study drug administration)

研究者

发起方
Grace Lim, MD, MS
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Grace Lim, MD, MS

Associate Professor

University of Pittsburgh

研究点 (1)

Loading locations...

相似试验